Alembic Pharmaceuticals net profit dropped 23% YoY to ₹138.4 crore in Q3 FY25 from ₹180.4 crore in the same quarter of last ...

The contract is an EPC contract and encompasses the design, engineering, manufacturing, supply, erection, commissioning, and civil works.

However, the company stated that its revenue from operations registered a growth of 66.90% to ₹534.70 Crore in Q3FY25.

As part of the contract, debentures shall have a tenure of 3,651 days (approx. 10 years) and shall be listed on the Wholesale ...

The deal is aimed at improving operational efficiency, expanding capabilities, and fuel innovation in the maritime sector.

The revenue increased by 8% YoY to ₹11,995 crores against ₹11,066 crores in Q3 FY24 due to strong demand in the market.